[{"status":"ok","data":{"results":[{"id":159282,"title":"Obama seeks support for $5bn counter-terrorism fund","type":"article","status":"live","url":"http:\/\/www.ft.com\/fastft?post=159282","shorturl":"http:\/\/on.ft.com\/1nBjUNL\n","content":"<p>President Barack Obama called on Wednesday for the creation of a $5bn fund to support counter-terrorism efforts in the Middle East and Africa to deal with a threat from al-Qaeda which had become more \"diffuse\".<\/p>\n\n<p>Speaking at West Point, Mr Obama said that terrorism still remained the biggest threat to the country but that the US needed to find new ways to address the risks from al-Qaeda that have spread well beyond Afghanistan and Pakistan, <strong>reports Geoff Dyer in Washington.<\/strong><\/p>\n\n<p>The new fund, which he asked Congress to approve, would allow the US to \"train, build capacity, and facilitate partner countries on the front lines and give us flexibility to fulfil different missions,\" Mr Obama said.<\/p>\n\n<p>The speech was designed to address the mounting criticism that Mr Obama is facing about a lack of direction in his foreign policy, as he is buffeted between crises in Ukraine, Syria and the South China Sea.<\/p>\n\n<p>Embracing the language of America as an \"exceptional\" and \"indispensable\" nation, Mr Obama insisted that the US would take unilateral military action if its \"core interests\" were challenged, including \"when the security of our allies is in danger\". <\/p>\n\n<p>But he also warned against the \"costly mistakes\" that come \"from our willingness to rush into military adventures \u2013 without thinking through the consequences\". He added: \"Tough talk draws headlines, but war rarely conforms to slogans.\"<\/p>\n\n<p>Attempting to find a middle path between the war-weariness of the current public mood and the interventionist ideas of many of his critics, Mr Obama said: \"America must always lead on the world stage. If we don't, no one else will\u2026.. But U.S. military action cannot be the only \u2013 or even primary \u2013 component of our leadership.\"<\/p>\n\n<p>He added: \"Just because we have the best hammer does not mean that every problem is a nail.\"<\/p>","abstract":"<p>President Barack Obama called on Wednesday for the creation of a $5bn fund to support counter-terrorism efforts in the Middle East and Africa to deal with a threat from al-Qaeda which had become more \"diffuse\".<\/p>","datepublished":"1401291128","authorpseudonym":"Richard Blackden","currentrevision":4391732,"attachments":[],"metadata":{"primarytagid":"113072"},"issticky":false,"tags":[{"tag":"Barack Obama","id":88952,"tagid":88952,"tx":"Person","txprefix":"person","txid":4020,"query":"person:\"Barack Obama\"","classname":null},{"tag":"World News","id":113072,"tagid":113072,"tx":"Topic","txprefix":"topic","txid":4000,"query":"topic:\"World News\"","classname":"turquoise"},{"tag":"US","id":119052,"tagid":119052,"tx":"Location","txprefix":"location","txid":4030,"query":"location:US","classname":null}],"uuidv3":"ef187e12-2ae7-3778-86d2-6252efbd051b","sortval":"0-0-01401291128"},{"id":159252,"title":"Treasury yields touch new low for 2014","type":"article","status":"live","url":"http:\/\/www.ft.com\/fastft?post=159252","shorturl":"http:\/\/on.ft.com\/1nUo4P2\n","content":"<p>What will it take for US government bond yields to rise?<\/p>\n\n<p>The question has become more acute as Treasuries sustain a rally that has pushed yields, which move in the opposite direction to a bond's price, to levels few anticipated at the start of the year.<\/p>\n\n<p>Ten-year yields touched a fresh low for the year of 2.45 per cent on Wednesday, as yields on all maturities declined.<\/p>\n\n<p>Although a disappointing first quarter for the US economy fanned demand for Treasuries, the rally has continued even as growth begins to regain some momentum (see chart below). <\/p>\n\n<p>Analysts have offered up various explanations, including the view that the US economy's growth potential has been permanently impaired by the financial crisis. That, in turn, would suggest a lower overall level of interest rates and bond yields. <\/p>\n\n<p>Here are strategists at Bank of America Merrill Lynch:<\/p>\n\n<blockquote>\n  <p>The market is pricing in a late start and\/or an extremely slow pace of the \n  hiking cycle. In our view, this is partly due to growing skepticism about the \n  economy's longer-term growth potential, which caused front end yields to decline in sympathy with the more sizable re-pricing of longer-term rates. <\/p>\n<\/blockquote>\n\n<p>And fixed-income strategists at Royal Bank of Scotland argue that lower yields are likely. <\/p>\n\n<blockquote>\n  <p>Treasury 10yr yields are still in the grips of their longer term range between ~2.47% and 3.00%. <\/p>\n  \n  <p>That said, a lingering investor short base and favorable valuations versus other liquid, 'safe haven' debt markets, means that any dips from resistance are likely to be shallow.<\/p>\n<\/blockquote>","abstract":"<p>What will it take for US government bond yields to rise?<\/p>","datepublished":"1401288416","authorpseudonym":"Richard Blackden","currentrevision":4391602,"attachments":[{"id":93032,"postid":159252,"userid":24302,"title":"treasuriesmay28.PNG","path":"\/2014-05\/28\/treasuriesmay28.PNG","mimetype":"image\/png","size":29140,"content":"<div class='formatted-img' data-src='http:\/\/clamo.ftdata.co.uk\/files\/2014-05\/28\/treasuriesmay28.PNG'><\/div>"}],"metadata":{"primarytagid":"86352"},"issticky":false,"tags":[{"tag":"Markets","id":86352,"tagid":86352,"tx":"Topic","txprefix":"topic","txid":4000,"query":"topic:Markets","classname":"orange-2"},{"tag":"Treasuries","id":115941,"tagid":115941,"tx":"Topic","txprefix":"topic","txid":4000,"query":"topic:Treasuries","classname":null},{"tag":"US","id":119052,"tagid":119052,"tx":"Location","txprefix":"location","txid":4030,"query":"location:US","classname":null}],"uuidv3":"72d0e72b-bd7b-3eac-b376-e2ba2593ffce","sortval":"0-0-01401288416"},{"id":159272,"title":"Frontier markets smell six-year high","type":"article","status":"live","url":"http:\/\/www.ft.com\/fastft?post=159272","shorturl":"http:\/\/on.ft.com\/1nUsk0Z\n","content":"<p>Frontier markets are within a small mouse's whisker of hitting a six-year high after climbing for five straight days.<\/p>\n\n<p>Today's 0.4 per cent gain in the FTSE Frontier Markets index was powered by Nigeria and Vietnam, which gained 0.6 per cent and 0.8 per cent respectively, and Romania, Serbia and Argentina, where local exchanges all gained about 0.5 per cent.<\/p>\n\n<p>At its peak the wider frontier markets gauge hit an intraday high of 581.82 points, less than a point below the intraday high of 582.76 touched in January 2011. If that level had been breached the index would have been at its highest level since the 2008 financial crisis slide started.<\/p>\n\n<p>Several frontier markets have emerged as the new darlings of the international investment community, as asset managers search for hot new stories. Frontier markets are often illiquid, difficult to access and riddled with corporate governance problems, but their economies are for the most part growing far more quickly than emerging markets.<\/p>\n\n<p>Two charts below from Renaissance Capital shows how frontier market inflows have boomed in recent years. <\/p>\n\n<p>That means frontier markets have now eliminated the pricing premium typically enjoyed by their bigger, mainstream counterparts. The MSCI Frontier Markets index is trading at an overall forward-looking price-to-earnings ratio of 12.7 times, compared to the emerging market gauge's 13 times. <\/p>\n\n<p>The remarkable performance is mirrored in fixed income markets, where hunger for yield has allowed a spate of countries to sell bonds for the very first time in recent years. <\/p>\n\n<p>Still, as the International Monetary Fund's Min Zhu pointed out in a recent blog post, the robust inflows into frontier markets could be a \"<a href=\"http:\/\/on.ft.com\/1mQWDam\">double-edged sword<\/a>\". <\/p>","abstract":"<p>Frontier markets are within a small mouse's whisker of hitting a six-year high after climbing for five straight days.<\/p>","datepublished":"1401287884","authorpseudonym":"Robin Wigglesworth","currentrevision":4391442,"attachments":[{"id":93042,"postid":159272,"userid":24502,"title":"Capture(2).PNG","path":"\/2014-05\/28\/Capture(2).PNG","mimetype":"image\/png","size":94475,"content":"<div class='formatted-img' data-src='http:\/\/clamo.ftdata.co.uk\/files\/2014-05\/28\/Capture%282%29.PNG'><\/div>"},{"id":93052,"postid":159272,"userid":24502,"title":"Capture2(1).PNG","path":"\/2014-05\/28\/Capture2(1).PNG","mimetype":"image\/png","size":42767,"content":"<div class='formatted-img' data-src='http:\/\/clamo.ftdata.co.uk\/files\/2014-05\/28\/Capture2%281%29.PNG'><\/div>"}],"metadata":{"primarytagid":"86352"},"issticky":false,"tags":[{"tag":"Markets","id":86352,"tagid":86352,"tx":"Topic","txprefix":"topic","txid":4000,"query":"topic:Markets","classname":"orange-2"},{"tag":"Emerging Markets","id":113212,"tagid":113212,"tx":"Topic","txprefix":"topic","txid":4000,"query":"topic:\"Emerging Markets\"","classname":null},{"tag":"Frontier markets","id":128632,"tagid":128632,"tx":"Topic","txprefix":"topic","txid":4000,"query":"topic:\"Frontier markets\"","classname":null}],"uuidv3":"4e6050cb-f069-39e1-befb-f60004e8855d","sortval":"0-0-01401287884"},{"id":159262,"title":"Hannam loses challenge to market abuse ruling","type":"article","status":"live","url":"http:\/\/www.ft.com\/fastft?post=159262","shorturl":"http:\/\/on.ft.com\/1nB7ZzJ\n","content":"<p>One of the City of London's most prominent dealmakers has lost his challenge to a ruling that he committed market abuse, in a high-profile dispute with UK regulators that was widely seen as a test case over what is considered inside information. <\/p>\n\n<p>Ian Hannam, the former co-head of UK capital markets at JPMorgan Cazenove known for his buccaneering spirit in bringing natural-resources companies such as Kazakhmys and Bumi to the London market, was hit with a hefty\u00a3450,000 fine in 2012 by the Financial Services Authority, after the watchdog (now known as the Financial Conduct Authority) ruled he had improperly disclosed information about Heritage Oil in two emails sent by him to the Kurdish oil minister, Ashti Hawrami, in 2008. <\/p>\n\n<p>Heritage, a close client of Mr Hannam, was drilling for oil in Uganda at the time, and searching for a merger partner in the Iraqi region.<\/p>\n\n<p>The Kurdish government, meanwhile, was both a prospective client of the bank's, and was looking to acquire a stake in Heritage.<\/p>\n\n<p>The first email, sent in September 2008, concerned a potential\nthird party bid for Heritage, while the second email, from October, related to positive developments about the company's oil exploration operations.<\/p>\n\n<p>An appeals tribunal has rejected Mr Hannam's argument that he didn't break UK market rules in sending the emails, saying his actions \"were not in the proper course of the exercise of his employment.\" <\/p>\n\n<p>From the ruling: <\/p>\n\n<blockquote>\n  <p>Mr Hannam's actions in sending both the September email and the October\n  email constituted behaviour falling within the [Financial Services and Markets Act.] He was thereby\n  engaged in market abuse. His actions were not in the proper course of the exercise\n  of his employment. <\/p>\n<\/blockquote>\n\n<p>It's an important victory for the FCA, which has sought to step up its enforcement of insider dealing and information sharing in the City. The appeals tribunal said it would deal with the question of the appropriate penalty at a later date, but it could be higher (or lower) than the original \u00a3450,000 sanction. <\/p>\n\n<p>Mr Hannam, who has vigorously disputed the FSA's original conclusions, said he would weigh launching a further appeal only after \"careful thought.\"<\/p>\n\n<blockquote>\n  <p>I am obviously disappointed that the Tribunal has rejected the explanation as to why the two emails sent in the course of advising and assisting my client did not contravene the rules, but I do appreciate the full consideration that has been given to the issues.<\/p>\n<\/blockquote>","abstract":"<p>One of the City of London's most prominent dealmakers has lost his challenge to a ruling that he committed market abuse, in a high-profile dispute with UK regulators that was widely seen as a test case over what is considered inside information.<\/p>","datepublished":"1401287256","authorpseudonym":"Megan Murphy","currentrevision":4391532,"attachments":[],"metadata":{"primarytagid":"113072"},"issticky":false,"tags":[{"tag":"UK","id":98232,"tagid":98232,"tx":"Location","txprefix":"location","txid":4030,"query":"location:UK","classname":null},{"tag":"World News","id":113072,"tagid":113072,"tx":"Topic","txprefix":"topic","txid":4000,"query":"topic:\"World News\"","classname":"turquoise"}],"uuidv3":"3e2f928b-1ab3-32c7-ac13-dbf8cdccdb88","sortval":"0-0-01401287256"},{"id":159242,"title":"Tablet PC shipments fall for first time","type":"article","status":"live","url":"http:\/\/www.ft.com\/fastft?post=159242","shorturl":"http:\/\/on.ft.com\/1nUhOXD\n","content":"<p>This isn't the iPad going the way of the iPod, but it is a significant data point.<\/p>\n\n<p>Global tablet shipments have fallen for the first time, according to the NPD DisplaySearch Quarterly Mobile PC Shipment and Forecast Report.<\/p>\n\n<p>Shipments in the first quarter of 2014 fell to 56.3m units, compared to 59m a year earlier.<\/p>\n\n<p>Tablet PCs still accounted for over half of all mobile PC shipments, which totalled 99m, compared to 104.4m in the first quarter of 2013.<\/p>\n\n<p>Additionally: <\/p>\n\n<blockquote>\n  <p>Standard notebook PC shipments were also down 14 per cent, from 40.7m units in Q1 2013 to 35m units in Q1 2014; ultra-slim PC shipments rose 62 per cent -- over a low base 4.8m units in Q1 2013 -- to 7.8m units in Q1 2014.<\/p>\n  \n  <p>With 20 per cent market share, Apple maintained the top position in the mobile PC market with nearly twice the share of second-ranked Samsung (11 per cent)<\/p>\n<\/blockquote>\n\n<p>DisplaySearch analysts say the tablet category is facing serious challenges from the emergence of large-screen smartphones.<\/p>\n\n<p>Here's the chart on mobile PC shipments by brand:<\/p>","abstract":"<p>This isn't the iPad going the way of the iPod, but it is a significant data point.<\/p>","datepublished":"1401285084","authorpseudonym":"Chris Nuttall","currentrevision":4390372,"attachments":[{"id":93012,"postid":159242,"userid":24432,"title":"tablets.PNG","path":"\/2014-05\/28\/tablets.PNG","mimetype":"image\/png","size":34082,"content":"<div class='formatted-img' data-src='http:\/\/clamo.ftdata.co.uk\/files\/2014-05\/28\/tablets.PNG'><\/div>"}],"metadata":{"primarytagid":"113002"},"issticky":false,"tags":[{"tag":"Apple","id":101432,"tagid":101432,"tx":"Company","txprefix":"company","txid":4050,"query":"company:Apple","classname":null},{"tag":"Companies","id":113002,"tagid":113002,"tx":"Sector","txprefix":"sector","txid":4010,"query":"sector:Companies","classname":"blue-2"},{"tag":"Tech","id":113042,"tagid":113042,"tx":"Sector","txprefix":"sector","txid":4010,"query":"sector:Tech","classname":null},{"tag":"US","id":119052,"tagid":119052,"tx":"Location","txprefix":"location","txid":4030,"query":"location:US","classname":null}],"uuidv3":"16ad3c89-aee7-37c1-92be-32e72d726f0c","sortval":"0-0-01401285084"},{"id":159232,"title":"McDonald's boosts cash return to investors","type":"article","status":"live","url":"http:\/\/www.ft.com\/fastft?post=159232","shorturl":"http:\/\/on.ft.com\/1nUd6sS\n","content":"<p>Even if Americans aren't gorging on its menus on the scale they once did, fast food chain <a href=\"http:\/\/markets.ft.com\/research\/Markets\/Tearsheets\/Summary?s=MCD:NYQ\">McDonald's<\/a> is serving up fresh share buybacks and higher dividends for investors.<\/p>\n\n<p>Don Thompson, the chief executive who has been battling to reverse falling sales in the US, said that the company will return between $18bn and $20bn to shareholders between now and 2016.<\/p>\n\n<p>That total, the company said on Wednesday, is 10 per cent to 20 per cent higher than the amount it returned between 2011 and 2013.<\/p>\n\n<p>Alongside that plan, McDonald's said it will refranchise more than 1,500 of its restaurants, as it seeks to reignite the attraction of the brand for consumers.<\/p>\n\n<p>The Chicago-based company is overhauling its menu in the US as it fights back against competition from the likes of Taco Bell. <\/p>\n\n<p>Shares in McDonald's were down 1.1 per cent at $101.23 in early morning trading in New York. They are little changed over the last 12 months.<\/p>","abstract":"<p>Even if Americans aren't gorging on its menus on the scale they once did, fast food chain <a href=\"http:\/\/markets.ft.com\/research\/Markets\/Tearsheets\/Summary?s=MCD:NYQ\">McDonald's<\/a> is serving up fresh share buybacks and higher dividends for investors.<\/p>","datepublished":"1401284032","authorpseudonym":"Richard Blackden","currentrevision":4390552,"attachments":[{"id":93022,"postid":159232,"userid":24302,"title":"http:\/\/markets.ft.com\/RESEARCH\/API\/ChartBuilder?t=equities&p=eyJzeW1ib2wiOiIxOTc2MDZ8NTc1NzY5IiwicmV","path":"http:\/\/markets.ft.com\/RESEARCH\/API\/ChartBuilder?t=equities&p=eyJzeW1ib2wiOiIxOTc2MDZ8NTc1NzY5IiwicmVnaW9uIjpudWxsLCJoZWlnaHQiOiIzMzgiLCJ3aWR0aCI6IjYwMCIsImxpbmVTdHlsZSI6Im1vdW50YWluIiwiZHVyYXRpb24iOiIzNjUiLCJzdGFydERhdGUiOm51bGwsImVuZERhdGUiOm51bGwsInByaW1hcnlMYWJlbCI6Ik1DRDpOWVEiLCJzZWNvbmRhcnlMYWJlbCI6IlMmUCA1MDAiLCJ0ZXJ0aWFyeUxhYmVsIjpudWxsLCJxdWF0ZXJuYXJ5TGFiZWwiOm51bGwsImlzTW9iaWxlIjpmYWxzZSwiU2hvd0Rpc2NsYWltZXIiOnRydWUsInVuaXQiOiJweCJ9","mimetype":"image\/gif","size":15452,"content":"<div class='formatted-img' data-src='http:\/\/markets.ft.com\/RESEARCH\/API\/ChartBuilder?t=equities&amp;p=eyJzeW1ib2wiOiIxOTc2MDZ8NTc1NzY5IiwicmVnaW9uIjpudWxsLCJoZWlnaHQiOiIzMzgiLCJ3aWR0aCI6IjYwMCIsImxpbmVTdHlsZSI6Im1vdW50YWluIiwiZHVyYXRpb24iOiIzNjUiLCJzdGFydERhdGUiOm51bGwsImVuZERhdGUiOm51bGwsInByaW1hcnlMYWJlbCI6Ik1DRDpOWVEiLCJzZWNvbmRhcnlMYWJlbCI6IlMmUCA1MDAiLCJ0ZXJ0aWFyeUxhYmVsIjpudWxsLCJxdWF0ZXJuYXJ5TGFiZWwiOm51bGwsImlzTW9iaWxlIjpmYWxzZSwiU2hvd0Rpc2NsYWltZXIiOnRydWUsInVuaXQiOiJweCJ9'><\/div>"}],"metadata":{"primarytagid":"113002"},"issticky":false,"tags":[{"tag":"McDonald's","id":102962,"tagid":102962,"tx":"Company","txprefix":"company","txid":4050,"query":"company:McDonald's","classname":null},{"tag":"Companies","id":113002,"tagid":113002,"tx":"Sector","txprefix":"sector","txid":4010,"query":"sector:Companies","classname":"blue-2"},{"tag":"US","id":119052,"tagid":119052,"tx":"Location","txprefix":"location","txid":4030,"query":"location:US","classname":null},{"tag":"Don Thompson","id":126852,"tagid":126852,"tx":"Person","txprefix":"person","txid":4020,"query":"person:\"Don Thompson\"","classname":null},{"tag":"share buybacks","id":128622,"tagid":128622,"tx":"Topic","txprefix":"topic","txid":4000,"query":"topic:\"share buybacks\"","classname":null}],"uuidv3":"04bb353a-e132-315a-9c46-a0f671d38697","sortval":"0-0-01401284032"},{"id":159222,"title":"Stryker says it won't bid for Smith & Nephew","type":"article","status":"live","url":"http:\/\/www.ft.com\/fastft?post=159222","shorturl":"http:\/\/on.ft.com\/1nAShV2\n","content":"<p>Stryker's out with a statement on <em>fast<\/em>FT's earlier report that it's <a href=\"http:\/\/www.ft.com\/fastft\">working on a takeover bid<\/a> for UK rival Smith &amp; Nephew. <\/p>\n\n<p>Having denied now on Wednesday it would make an offer, Stryker is now barred from coming back with a bid for six months, except in certain circumstances, under UK takeover rules. <\/p>\n\n<p>Here's the full statement: <\/p>\n\n<blockquote>\n  <p>Stryker notes the recent speculation regarding a potential transaction involving Smith &amp; Nephew plc (\"Smith &amp; Nephew\") and recent movement in the share price of Smith &amp; Nephew.<\/p>\n  \n  <p>At the request of the UK Takeover Panel, Stryker confirms that it does not intend to make an offer for Smith &amp; Nephew. Accordingly, Stryker is bound by the restrictions under Rule 2.8 of the UK Takeover Code (the \"Code\").<\/p>\n  \n  <p>For the purposes of Rule 2.8 of the Code, Stryker reserves the right to announce or participate in an offer or possible offer for Smith &amp; Nephew and\/or to take any other action which would otherwise be restricted under Rule 2.8 of the Code within 6 months after the date of this announcement in the circumstances described in note 2 to Rule 2.8 of the Code.<\/p>\n<\/blockquote>","abstract":"<p>Stryker's out with a statement on <em>fast<\/em>FT's earlier report that it's <a href=\"http:\/\/www.ft.com\/fastft\">working on a takeover bid<\/a> for UK rival Smith &amp; Nephew.<\/p>","datepublished":"1401283762","authorpseudonym":"Megan Murphy","currentrevision":4390492,"attachments":[],"metadata":{"primarytagid":"113002"},"issticky":false,"tags":[{"tag":"Companies","id":113002,"tagid":113002,"tx":"Sector","txprefix":"sector","txid":4010,"query":"sector:Companies","classname":"blue-2"},{"tag":"Stryker","id":116882,"tagid":116882,"tx":"Company","txprefix":"company","txid":4050,"query":"company:Stryker","classname":null}],"uuidv3":"2857f95c-aa4c-32f0-858d-b8501a93a561","sortval":"0-0-01401283762"},{"id":159212,"title":"Smith & Nephew and Stryker shares jump","type":"article","status":"live","url":"http:\/\/www.ft.com\/fastft?post=159212","shorturl":"http:\/\/on.ft.com\/1nU7I9c\n","content":"<p>Pfizer's shares didn't react well to the company's proposed \u00a369.4bn takeover of AstraZeneca. Those of US medical device manufacturer <a href=\"http:\/\/markets.ft.com\/research\/Markets\/Tearsheets\/Summary?s=SYK:NYQ\">Stryker<\/a> are having a different reaction to <a href=\"http:\/\/on.ft.com\/1nAEDkN\">the FT's report<\/a> that it is readying a bid for UK rival Smith &amp; Nephew.<\/p>\n\n<p>Shares in Stryker, which is based in Michigan and makes equipment used in knee and hip surgery, climbed 6 per cent to $85.98 in pre-market trading in New York on Wednesday.<\/p>\n\n<p>Shares of <a href=\"http:\/\/markets.ft.com\/research\/Markets\/Tearsheets\/Summary?s=SN.:LSE\">Smith &amp; Nephew,<\/a> a maker of replacement hips, surged 11 per cent to \u00a310.80 in early afternoon trading in London.<\/p>\n\n<p>Stryker is preparing a takeover bid for Smith &amp; Nephew in what would be the latest multi-billion dollar healthcare deal to hit the market this year, <strong>Ed Hammond, Neil Hume and Andrew Ward report.<\/strong><\/p>","abstract":"<p>Pfizer's shares didn't react well to the company's proposed \u00a369.4bn takeover of AstraZeneca. Those of US medical device manufacturer <a href=\"http:\/\/markets.ft.com\/research\/Markets\/Tearsheets\/Summary?s=SYK:NYQ\">Stryker<\/a> are having a different reaction to <a href=\"http:\/\/on.ft.com\/1nAEDkN\">the FT's report<\/a> that it is readying a bid for UK rival Smith &amp; Nephew.<\/p>","datepublished":"1401282670","authorpseudonym":"Richard Blackden","currentrevision":4389962,"attachments":[{"id":92992,"postid":159212,"userid":24302,"title":"http:\/\/markets.ft.com\/RESEARCH\/API\/ChartBuilder?t=equities&p=eyJzeW1ib2wiOiIyNTYzMzV8MjY0MDkxIiwicmV","path":"http:\/\/markets.ft.com\/RESEARCH\/API\/ChartBuilder?t=equities&p=eyJzeW1ib2wiOiIyNTYzMzV8MjY0MDkxIiwicmVnaW9uIjpudWxsLCJoZWlnaHQiOiIzMzgiLCJ3aWR0aCI6IjYwMCIsImxpbmVTdHlsZSI6Im1vdW50YWluIiwiZHVyYXRpb24iOiIzNjUiLCJzdGFydERhdGUiOm51bGwsImVuZERhdGUiOm51bGwsInByaW1hcnlMYWJlbCI6IlNOLjpMU0UiLCJzZWNvbmRhcnlMYWJlbCI6IlNZSzpOWVEiLCJ0ZXJ0aWFyeUxhYmVsIjpudWxsLCJxdWF0ZXJuYXJ5TGFiZWwiOm51bGwsImlzTW9iaWxlIjpmYWxzZSwiU2hvd0Rpc2NsYWltZXIiOnRydWUsInVuaXQiOiJweCJ9","mimetype":"image\/gif","size":14789,"content":"<div class='formatted-img' data-src='http:\/\/markets.ft.com\/RESEARCH\/API\/ChartBuilder?t=equities&amp;p=eyJzeW1ib2wiOiIyNTYzMzV8MjY0MDkxIiwicmVnaW9uIjpudWxsLCJoZWlnaHQiOiIzMzgiLCJ3aWR0aCI6IjYwMCIsImxpbmVTdHlsZSI6Im1vdW50YWluIiwiZHVyYXRpb24iOiIzNjUiLCJzdGFydERhdGUiOm51bGwsImVuZERhdGUiOm51bGwsInByaW1hcnlMYWJlbCI6IlNOLjpMU0UiLCJzZWNvbmRhcnlMYWJlbCI6IlNZSzpOWVEiLCJ0ZXJ0aWFyeUxhYmVsIjpudWxsLCJxdWF0ZXJuYXJ5TGFiZWwiOm51bGwsImlzTW9iaWxlIjpmYWxzZSwiU2hvd0Rpc2NsYWltZXIiOnRydWUsInVuaXQiOiJweCJ9'><\/div>"}],"metadata":{"primarytagid":"113002"},"issticky":false,"tags":[{"tag":"Smith & Nephew","id":106392,"tagid":106392,"tx":"Company","txprefix":"company","txid":4050,"query":"company:\"Smith & Nephew\"","classname":null},{"tag":"Companies","id":113002,"tagid":113002,"tx":"Sector","txprefix":"sector","txid":4010,"query":"sector:Companies","classname":"blue-2"},{"tag":"Stryker","id":116882,"tagid":116882,"tx":"Company","txprefix":"company","txid":4050,"query":"company:Stryker","classname":null}],"uuidv3":"2c7e4c9a-f031-39ce-aa64-5d9c81851884","sortval":"0-0-01401282670"},{"id":159162,"title":"US is World Cup hotshot thanks to per capita GDP","type":"article","status":"live","url":"http:\/\/www.ft.com\/fastft?post=159162","shorturl":"http:\/\/on.ft.com\/1nAtYGP\n","content":"<p>How's this for a World Cup footy prediction that only a financial analyst could write?:<\/p>\n\n<blockquote>\n  <p>We believe the heavily populated wealthy US stands a good chance of advancing far into the tournament. We believe it is likely to get \n  the upper hand over debt-burdened Portugal in the preliminary stage.<\/p>\n<\/blockquote>\n\n<p>Fair enough, but Portugal's star player Cristiano Ronaldo hardly lacks a euro or two and is not short on goals either, scoring more than 50 this season.<\/p>\n\n<p>But Danske Bank analysts insist, in <a href=\"http:\/\/danskeanalyse.danskebank.dk\/link\/WorldCUp2014Specialfinal\/$file\/WorldCUp2014Special_final.pdf\">their analysis of next month's World Cup:<\/a><\/p>\n\n<blockquote>\n  <p>Economic fundamentals play a vital role in determining who will come out on top. $20,000 in extra GDP per capita earns a team a 0.1 goal advantage at the World Cup. This should give reason for comfort in the US camp, as the $30,000 difference in GDP per capita should give it a 0.15 goal advantage over Portugal when the two teams meet.<\/p>\n<\/blockquote>\n\n<p>Danske does take in footballing factors as well, such as home advantage, and makes Brazil favourites to lift the trophy after beating England in the quarter finals, Germany in the semi-finals and Argentina in the final. It rates its chances of winning the World Cup as a 45.1 per cent probability (see table).<\/p>\n\n<p>That's similar to the <a href=\"http:\/\/www.goldmansachs.com\/our-thinking\/outlook\/world-cup-and-economics-2014-folder\/world-cup-economics-report.pdf\">48.5 per cent probability in Goldman Sachs World Cup report.<\/a><\/p>\n\n<p>So that's Brazil at around an even money chance with analysts, compared to <a href=\"http:\/\/www.oddschecker.com\/football\/world-cup\/winner\">current odds of 3\/1<\/a> with the bookmakers, making its team an undervalued stock if betting shop punters are looking to fill their football boots.<\/p>","abstract":"<p>How's this for a World Cup footy prediction that only a financial analyst could write?:<\/p>","datepublished":"1401282037","authorpseudonym":"Chris Nuttall","currentrevision":4389812,"attachments":[{"id":92962,"postid":159162,"userid":24432,"title":"worldcup.PNG","path":"\/2014-05\/28\/worldcup.PNG","mimetype":"image\/png","size":82698,"content":"<div class='formatted-img' data-src='http:\/\/clamo.ftdata.co.uk\/files\/2014-05\/28\/worldcup.PNG'><\/div>"}],"metadata":{"primarytagid":"113092"},"issticky":false,"tags":[{"tag":"Brazil","id":98512,"tagid":98512,"tx":"Location","txprefix":"location","txid":4030,"query":"location:Brazil","classname":null},{"tag":"Comment","id":113092,"tagid":113092,"tx":"Topic","txprefix":"topic","txid":4000,"query":"topic:Comment","classname":"purple"},{"tag":"World Cup","id":118922,"tagid":118922,"tx":"Topic","txprefix":"topic","txid":4000,"query":"topic:\"World Cup\"","classname":null}],"uuidv3":"d6e9121f-57ea-3887-ac07-de718fd97410","sortval":"0-0-01401282037"},{"id":159202,"title":"Allergan to review Valeant's sweetened bid","type":"article","status":"live","url":"http:\/\/www.ft.com\/fastft?post=159202","shorturl":"http:\/\/on.ft.com\/1nU59Ej\n","content":"<p>Will the chief executives of <a href=\"http:\/\/markets.ft.com\/research\/Markets\/Tearsheets\/Summary?s=AGN:NYQ\">Allergan<\/a> and <a href=\"http:\/\/markets.ft.com\/research\/Markets\/Tearsheets\/Summary?s=VRX:TOR\">Valeant<\/a> soon be sitting around a table musing about global demand for Botox?<\/p>\n\n<p>That's what US pharmaceutical company Valeant urged Allergan, the maker of Botox, to do on Wednesday as it sweetened its takeover proposal.<\/p>\n\n<p>Two hours later, Allergan has delivered its response. In a statement, the company said its board will <\/p>\n\n<blockquote>\n  <p>Carefully review and consider the Revised Proposal and pursue the course of action that the Board\n  believes is in the best interests of the Company and all of its stockholders.<\/p>\n  \n  <p>No action by Allergan's stockholders is required at this time. <\/p>\n<\/blockquote>\n\n<p><a href=\"http:\/\/www.ft.com\/intl\/cms\/s\/0\/9d31ee7c-e654-11e3-bbf5-00144feabdc0.html\">Here<\/a> is a full story on Valeant's higher bid, the latest chapter in a bitter series of public exchanges between the two companies.<\/p>","abstract":"<p>Will the chief executives of <a href=\"http:\/\/markets.ft.com\/research\/Markets\/Tearsheets\/Summary?s=AGN:NYQ\">Allergan<\/a> and <a href=\"http:\/\/markets.ft.com\/research\/Markets\/Tearsheets\/Summary?s=VRX:TOR\">Valeant<\/a> soon be sitting around a table musing about global demand for Botox?<\/p>","datepublished":"1401281810","authorpseudonym":"Richard Blackden","currentrevision":4390002,"attachments":[{"id":93002,"postid":159202,"userid":24302,"title":"http:\/\/markets.ft.com\/RESEARCH\/API\/ChartBuilder?t=equities&p=eyJzeW1ib2wiOiI2NzY5Nnw0MDc0NyIsInJlZ2l","path":"http:\/\/markets.ft.com\/RESEARCH\/API\/ChartBuilder?t=equities&p=eyJzeW1ib2wiOiI2NzY5Nnw0MDc0NyIsInJlZ2lvbiI6bnVsbCwiaGVpZ2h0IjoiMzM4Iiwid2lkdGgiOiI2MDAiLCJsaW5lU3R5bGUiOiJsaW5lIiwiZHVyYXRpb24iOiIzNjUiLCJzdGFydERhdGUiOm51bGwsImVuZERhdGUiOm51bGwsInByaW1hcnlMYWJlbCI6IlZSWDpUT1IiLCJzZWNvbmRhcnlMYWJlbCI6IkFHTjpOWVEiLCJ0ZXJ0aWFyeUxhYmVsIjpudWxsLCJxdWF0ZXJuYXJ5TGFiZWwiOm51bGwsImlzTW9iaWxlIjpmYWxzZSwiU2hvd0Rpc2NsYWltZXIiOnRydWUsInVuaXQiOiJweCJ9","mimetype":"image\/gif","size":11642,"content":"<div class='formatted-img' data-src='http:\/\/markets.ft.com\/RESEARCH\/API\/ChartBuilder?t=equities&amp;p=eyJzeW1ib2wiOiI2NzY5Nnw0MDc0NyIsInJlZ2lvbiI6bnVsbCwiaGVpZ2h0IjoiMzM4Iiwid2lkdGgiOiI2MDAiLCJsaW5lU3R5bGUiOiJsaW5lIiwiZHVyYXRpb24iOiIzNjUiLCJzdGFydERhdGUiOm51bGwsImVuZERhdGUiOm51bGwsInByaW1hcnlMYWJlbCI6IlZSWDpUT1IiLCJzZWNvbmRhcnlMYWJlbCI6IkFHTjpOWVEiLCJ0ZXJ0aWFyeUxhYmVsIjpudWxsLCJxdWF0ZXJuYXJ5TGFiZWwiOm51bGwsImlzTW9iaWxlIjpmYWxzZSwiU2hvd0Rpc2NsYWltZXIiOnRydWUsInVuaXQiOiJweCJ9'><\/div>"}],"metadata":{"primarytagid":"113002"},"issticky":false,"tags":[{"tag":"Companies","id":113002,"tagid":113002,"tx":"Sector","txprefix":"sector","txid":4010,"query":"sector:Companies","classname":"blue-2"},{"tag":"US","id":119052,"tagid":119052,"tx":"Location","txprefix":"location","txid":4030,"query":"location:US","classname":null},{"tag":"Allergan","id":126732,"tagid":126732,"tx":"Company","txprefix":"company","txid":4050,"query":"company:Allergan","classname":null},{"tag":"Valeant Pharmaceuticals","id":126742,"tagid":126742,"tx":"Company","txprefix":"company","txid":4050,"query":"company:\"Valeant Pharmaceuticals\"","classname":null}],"uuidv3":"9dcde32b-7bc0-374c-b503-2e02e5492e30","sortval":"0-0-01401281810"}],"srh":{"query":{"id":4672,"str":"status:live","url":"status%3Alive","obj":{"op":"AND","st":"live","tms":[{"txid":null,"pr":"status","t":"live","tid":null}]},"hash":"2e54b842aa97f3121036669c83849703"},"sort":"date","limit":10,"offset":0,"dispopts":[]},"resultsummarytext":"14,555 results","total":14555,"filters":{"4000":{"id":4000,"name":"Topic","plural":"Topics","terms":{"1":{"tagid":"86032","freq":2911,"type":"inresults","tag":"Economy","term":"topic:Economy","isprotected":0},"0":{"tagid":"86352","freq":3560,"type":"inresults","tag":"Markets","term":"topic:Markets","isprotected":0}},"iscomplete":false,"summary":""},"4010":{"id":4010,"name":"Sector","plural":"Sectors","terms":[{"tagid":"113002","freq":6497,"type":"inresults","tag":"Companies","term":"sector:Companies","isprotected":0},{"tagid":"88632","freq":211,"type":"inresults","tag":"Retail","term":"sector:Retail","isprotected":0}],"iscomplete":false,"summary":""},"4020":{"id":4020,"name":"Person","plural":"People","terms":{"1":{"tagid":"89052","freq":129,"type":"inresults","tag":"Ben Bernanke","term":"person:\"Ben Bernanke\"","isprotected":0},"0":{"tagid":"114882","freq":135,"type":"inresults","tag":"Janet Yellen","term":"person:\"Janet Yellen\"","isprotected":0}},"iscomplete":false,"summary":""},"4030":{"id":4030,"name":"Location","plural":"Locations","terms":{"1":{"tagid":"98262","freq":1207,"type":"inresults","tag":"Asia","term":"location:Asia","isprotected":0},"0":{"tagid":"119052","freq":1748,"type":"inresults","tag":"US","term":"location:US","isprotected":0}},"iscomplete":false,"summary":""},"4040":{"id":4040,"name":"Institution","plural":"Institutions","terms":{"1":{"tagid":"100282","freq":202,"type":"inresults","tag":"ECB","term":"institution:ECB","isprotected":0},"0":{"tagid":"113542","freq":280,"type":"inresults","tag":"Federal Reserve","term":"institution:\"Federal Reserve\"","isprotected":0}},"iscomplete":false,"summary":""},"4050":{"id":4050,"name":"Company","plural":"Companies","terms":[{"tagid":"101432","freq":177,"type":"inresults","tag":"Apple","term":"company:Apple","isprotected":0},{"tagid":"101332","freq":164,"type":"inresults","tag":"RBS","term":"company:RBS","isprotected":0}],"iscomplete":false,"summary":""}}}}]